Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Cholinesterase (ChE)
    (2)
  • GPCR19
    (2)
  • YAP
    (2)
  • Beta-Secretase
    (1)
  • FLT
    (1)
  • GABA Receptor
    (1)
  • Histone Demethylase
    (1)
  • MAO
    (1)
  • Microtubule Associated
    (1)
  • Others
    (7)
TargetMol | Tags By ResearchField
  • Cancer
    (5)
  • Nervous System
    (3)
  • Immune System
    (2)
  • Inflammation
    (2)
  • Infection
    (1)
Filter
Search Result
Results for "

T7942

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    11
    TargetMol | All_Pathways
Tranylcypromine hemisulfate
Tranylcypromine Sulfate, Tranylcypromine (hemisulfate)
T794213492-01-8
Tranylcypromine hemisulfate (Tranylcypromine Sulfate) is an inhibitor of monoamine oxidase (MAO) and lysine-specific demethylase 1 (LSD1) with a rapid onset of activity.
  • $35
In Stock
Size
QTY
TargetMol | Citations Cited
FLT3-IN-22
T79420
FLT3-IN-22 (compound 22f) is a potent FLT3 inhibitor with IC50 values of 0.941 nM for FLT3 and 0.199 nM for the FLT3/D835Y mutant. It demonstrates significant antiproliferative effects against MV4-11 cells and Ba/F3 cell lines expressing mutant FLT kinase variants, including FLT-D835Y and FLT3-F691L [1].
  • Inquiry Price
Inquiry
Size
QTY
DCLK1-IN-2
T794212978517-43-8
DCLK1-IN-2 (Compound I-5) is a potent inhibitor of DCLK1, exhibiting an IC50 of 171.3 nM, and demonstrates significant antiproliferative effects on SW1990 cell lines with an IC50 of 0.6 μM, as well as in vivo antitumor potency [1].
  • $1,610
4-6 weeks
Size
QTY
BuChE-IN-8
T79422
BuChE-IN-8 (compound 19c), a butyrylcholinesterase (BuChE) inhibitor, exhibits an IC50 value of 559 nM and concurrently inhibits human β-secretase (BACE1) and Aβ40 aggregation. It also demonstrates notable antiamnesic properties [1].
  • Inquiry Price
Inquiry
Size
QTY
BuChE-IN-9
T79423
BuChE-IN-9 (compound 22a), an eqBuChE (equine serum-derived butyrylcholinesterase) inhibitor, exhibits potent activity with an IC50 of 173 nM. In addition to eqBuChE, it also inhibits human BACE1, Aβ aggregation, and mouse GABA transporters 1 and 4 (mGAT1 and mGAT4). Notably, BuChE-IN-9 demonstrates significant antiamnesic properties [1].
  • Inquiry Price
Inquiry
Size
QTY
TGR5 agonist 3
T794242148317-51-3
Compound 8, a cholic acid derivative, functions as a selective TGR5 agonist and exhibits an EC50 value of 5 μM [1].
  • $1,970
8-10 weeks
Size
QTY
TGR5 agonist 4
T79425
TGR5 agonist 4 (compound 19), a cholic acid derivative, selectively activates the TGR5 receptor with an EC50 of 4 μM [1].
  • Inquiry Price
Inquiry
Size
QTY
SARS-CoV-2-IN-61
T79426
SARS-CoV-2-IN-61 (compound 8i) is a potent SARS-CoV-2 PLpro inhibitor, with an IC50 of 16 µM, and exhibits antiviral activities [1].
  • Inquiry Price
Inquiry
Size
QTY
LM-41
LM41
T794272996821-30-6
LM-41 is a TEAD-binding agent with potential anticancer activity that strongly reduces the expression of CTGF, Cyr61, Axl and NF2, and can be used in the study of breast cancer.
  • $75
In Stock
Size
QTY
AF-2112
T794282996821-62-4
AF-2112, a TEAD inhibitor derived from Flufenamic acid, significantly diminishes the expression of CTGF, Cyr61, Axl, and NF2.
  • $323
6-8 weeks
Size
QTY
Tubulin polymerization-IN-50
T79429
Tubulin Polymerization-IN-50 (compound 7n) serves as an inhibitor of tubulin polymerization, exhibiting an IC50 of 5.05 μM in SK-Mel-28 cells and inducing cell cycle arrest at the G2/M phase [1].
  • Inquiry Price
Inquiry
Size
QTY